(Q44645157)

5 December 2017

title

Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk (English)

1 reference

5 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

29 March 2024

author name string

Y. Miyoshi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

A. Ando

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

S. Hasegawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

M. Ishitobi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

J. Yamamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

N. Irahara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

Y. Tanji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

T. Taguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

Y. Tamaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

S. Noguchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602139

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14602139

29 March 2024

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0959804903007500?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

https://api.elsevier.com/content/article/PII:S0959804903007500?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

European Journal of Cancer

29 March 2024

published in

1 reference

5 December 2017

volume

39

1 reference

5 December 2017

issue

17

1 reference

5 December 2017

page(s)

2531-2537

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

A rare CYP19 (aromatase) variant may increase the risk of breast cancer

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

A tetranucleotide repeat polymorphism inCYP19 and breast cancer risk

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Breast cancer risk associated with polymorphism in CYP19 in Japanese women

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Role of Estradiol Metabolism and CYP1A1 Polymorphisms in Breast Cancer Risk

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

The importance of local synthesis of estrogen within the breast

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Aromatase expression in the human breast

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Transient induction of increased aldehyde dehydrogenase 3A1 levels in cultured human breast (adeno)carcinoma cell lines via 5'-upstream xenobiotic, and electrophile, responsive elements is, respectively, estrogen receptor-dependent and -independent

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines.

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2003.08.017

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference